Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Guj. Kidney & Super IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size 150.79 Cr
Profile
Price Range 108  to  114 per share
Profile
Min Investment ₹114
Profile
Lot Size 1
Profile
Face Value ₹2
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

We are one of the regional healthcare companies located in the central region of state of Gujarat and operate achain of mid-sized multispeciality hospitals, providing integrated healthcare services, with a focus on secondaryand tertiary care. As of March 20, 2025, on a consolidated basis, we operate six (06) multispeciality hospitals and(03) pharmacies operating within our Hospitals, Gujarat Kidney and Superspeciality Hospital (Vadodara), GujaratMultispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital andICU (Borsad), Gujarat Surgical Hospital (Vadodara), Ashwini Medical Centre (Anand) and Ashwini MedicalStore (Anand) with a total bed capacity of 400 beds, approved bed capacity of 355 beds and operational bedcapacity of 250 beds. We endeavour to address all the needs of our patients through our healthcare services. Read More

Basic Info

Face Value 2 per share

Price 108  to  114 per share

P/E (x) 60

Sales( Cr.) 40

PAT( Cr.) 9

EPS 1.9

Draft Prospectus

Exchange BSE-NSE

Promoter

Company Promoters

Pragnesh Yashwantsinh Bharpoda Bhartiben Pragnesh Bharpoda Yashwantsingh Motisinh Bharpoda Anitaben Yashwantsinh Bharpoda

Pre Issue Share Holding 99.1%

Post Issue Share Holding 71.45%

Listing Details:

Listing Price: 120

Listing Gain: 5%

Current Price: 137.5

Gain On Issue: 137.5 | 0%

GMP: 1.5

GMP %: 1.3 %

IPO Tentative Timetable

Opening Date Dec 22, 2025
Closing Date Dec 24, 2025
Allotment Dec 25, 2025
Refund Dec 26, 2025
Delivery of Shares Dec 26, 2025
Listing Date Dec 29, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 128 14,592
Retail (Max) 13 1664 189,696
S-HNI (Min) 14 1792 204,288
S-HNI (Max) 68 8704 992,256
B-HNI (Min) 69 8832 1,006,848

Objective of the Issue

1. Proposed acquisition of “Parekhs Hospital Private Limited” at Ahmedabad2. Part payment of purchase consideration for the already acquired hospital i.e. “Ashwini Medical Centre”3. Funding of capital expenditure requirements of our Company towards setting up of a new hospital exclusively for women’s health care in Vadodara 4. Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital at Vadodara location5. Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by our Company and6. Funding inorganic growth through unidentified acquisitions and General Corporate Purposes.

Issue

Category Nos Bid Bid (x)
QIB 7726880 8188928 1.1x
NII 3300000 18899840 5.7x
Retail 2200000 41880320 19x
EMP 0 0 0x
Total 13226880 68969088 5.2x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Guj. Kidney & Super Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 0 0 5 40
Other Income 1 0 1 0
Total Income 1 0 5 40
Total Expenditure 0 0 3 24
Operating Profit 1 -0 3 17
Interest 0 0 0 1
Depreciation 1 0 0 3
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax 0 -0 2 13
Provision for Tax 0 0 1 3
Profit After Tax 0 -0 2 9
Adjustments 0 0 0 -0
Profit After Adjustments 0 -0 2 9
Adjusted Earnings Per Share 0 -0 0.5 1.7

Guj. Kidney & Super Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 0 0 11 26
Minority's Interest 0 0 0 1
Borrowings 0 0 2 2
Other Non-Current Liabilities -0 -0 4 4
Total Current Liabilities 4 3 4 22
Total Liabilities 4 4 20 55
Fixed Assets 3 0 14 31
Other Non-Current Assets 0 3 0 2
Total Current Assets 1 1 7 22
Total Assets 4 4 20 55

Guj. Kidney & Super Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 1
Cash Flow from Operating Activities 0 0 1 14
Cash Flow from Investing Activities 0 0 0 -18
Cash Flow from Financing Activities 0 0 -0 6
Net Cash Inflow / Outflow 0 0 1 2
Closing Cash & Cash Equivalent 0 0 1 3

Guj. Kidney & Super Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.03 -0 0.49 1.66
CEPS(Rs) 0.19 -0 0.58 2.25
DPS(Rs) 0 0 0 0
Book NAV/Share(Rs) 0.11 0.11 0.5 4.56
Core EBITDA Margin(%) 0 0 40.86 41.12
EBIT Margin(%) 0 0 48.92 33.33
Pre Tax Margin(%) 0 0 47.51 31.72
PAT Margin (%) 0 0 35.9 23.61
Cash Profit Margin (%) 0 0 42.59 31.78
ROA(%) 2.61 -0.16 14.09 25.28
ROE(%) 26.56 -1.66 162.4 68.65
ROCE(%) 36.31 -1.66 35.61 63.02
Receivable days 0 0 204.57 87.78
Inventory Days 0 0 20.64 4.29
Payable days 0 0 3365.79 250.57
PER(x) 0 0 0 0
Price/Book(x) 0 0 0 0
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 0 0 0.2 0.31
EV/Core EBITDA(x) 0.28 -31.69 0.36 0.75
Net Sales Growth(%) 0 0 0 742.89
EBIT Growth(%) 0 -104.54 0 474.25
PAT Growth(%) 0 -106.2 0 454.22
EPS Growth(%) 0 -106.2 0 238.16
Debt/Equity(x) 0 0 1.12 0.15
Current Ratio(x) 0.33 0.33 1.59 1.01
Quick Ratio(x) 0.33 0.33 1.52 0.98
Interest Cover(x) 0 0 34.75 20.75
Total Debt/Mcap(x) 0 0 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 700% 0% 0% 0%
Operating Profit CAGR 467% 157% 0% 0%
PAT CAGR 350% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 69% 76% 64% 64%
ROCE Average 63% 32% 33% 33%

Company Contact Information

Gujarat Kidney And Super Speciality Ltd.

Niki Paresh Tiwari

+91 265 298 4800

info@gujaratsuperspecialityhospital.com

Plot No. 1, City Sarve No. 1537 / A Jetalpur Road, Gokak Mill Compound Alkapuri

IPO Lead Manager(s)

Gujarat Kidney And Super Speciality Ltd.

Nirbhay Capital Services Pvt Ltd.

Registrar Info

Gujarat Kidney And Super Speciality Ltd.

MUFG Intime India Pvt Ltd.

C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West), Mumbai Mumbai City Maharashtra 400083

rnt.helpdesk@in.mpms.mufg.com

https://in.mpms.mufg.com/

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!